GE Healthcare Developing a Digital Health Platform to Help Providers Accelerate Digital Transformation
Moment at HIMSS 2022, GE Healthcare blazoned its intention to introduce Edison Digital Health Platform, a seller-agnostic hosting and data aggregation platform with an intertwined artificial intelligence (AI) machine. The platform is being developed to enable hospitals and healthcare systems to effectively emplace the clinical, workflow, analytics and AI tools which would support the enhancement of care delivery, the creation of high- effectiveness operations, and the increase of profit growth, while also supporting reduction in the IT burden that generally comes with installing and integrating apps across the enterprise.
Edison Digital Health Platform is designed to accelerate app integration by connecting bias and other data sources into an aggregated clinical data subcaste. A collection of data metamorphosis services is anticipated to be available on the platform to support data logical operations, and to enable the training and deployment of AI models using the aggregated data. Through open and published interfaces, healthcare providers and third- party inventors are anticipated to be suitable to seamlessly emplace their operations, with the platform supporting integration of the apps into being workflows. In addition, GE Healthcare intends to integrate and emplace its own apps similar as Command Center “ penstocks” onto Edison Digital Health Platform.
“ Edison Digital Health Platform is being designed to enable healthcare systems to have a single platform on which to host and integrate apps into clinical workflows,” said Amit Phadnis, Chief Digital Officer, GE Healthcare. “ With easy access to the workflow, analytics, and clinical apps specific to care across the care continuum, clinicians will have practicable perceptivity at their fingertips to help better serve their cases.”
With Edison Digital Health Platform, IT departments are intended to profit from a one- time connection to multiple databases, similar as the EMR, during the first integration, after which posterior apps are anticipated to connect with lower trouble. With a seller-agnostic platform, providers would be suitable to elect stylish-in- class and preferred apps safely and securely, without the typical demand of multiple individual integrations or being locked into a single seller. In addition, the platform is being designed to gauge across pall, garçon, data center or on- device deployment. Leidos, a preferred premier systems integrator and GE Healthcare Strategic Alliance member, will unite with guests on flawless executions and applicable integrations.
“ We look forward to working alongside GE Healthcare to address health systems’technology challenges from the growing demand for app integration,” said Liz Porter, chairman of Leidos Health Group. “ The platform will help reduce digital disunion across the enterprise and accelerate the deployment of digital results at scale. This will help healthcare providers ameliorate effectiveness and drive better care for cases.”
According to Gartner ®, “ the DHP (digital health platform) shift will crop as the most cost-effective and technically effective way to gauge new digital capabilities within and across health ecosystems and will over time replace the monolithic period of the megasuite electronic health record (EHR).” (ii)
“ We anticipate Edison Digital Health Platform to be a game- changer for clinicians, particularly as it relates to patient data,” saidDr. Felix Nensa, a adviser radiologist at the University Hospital Essen and group leader at the Institute for Artificial Intelligence in Medicine. “ They will have the capability to have all of their cases’data listed and aggregated in one place, saving hours of time by reducing the need to search across colorful, distant systems to pierce applicable patient information.”
Forward- looking statements
This document contains “ forward- looking statements” — that is, statements related to future, not once, events. These forward- looking statements frequently address our anticipated unborn business and fiscal performance and fiscal condition, and frequently contain words similar as” anticipate,”” anticipate,”” intend,”” plan,”” believe,”” seek,”” see,””will,””would,”or “ target.”Forward- looking statements by their nature address matters that are, to different degrees, uncertain, and are subject to pitfalls, misgivings and hypotheticals. Should one or further of these pitfalls or misgivings materialize, or should underpinning hypotheticals prove incorrect, factual results may vary materially from those indicated or anticipated by similar forward- looking statements. The addition of similar statements shouldn’t be regarded as a representation that similar plans or prospects will be achieved. Important factors that could beget factual results to differ materially from similar plans or prospects include, among others, (1) that GE Healthcare isn’t suitable to design or develop the platform to meet anticipated functionality or clinical or functional objects; (2) the threat that the development and evaluation may not be completed in the anticipated time frame, or at all; and (3) other threat factors as detailed from time to time in GE’s reports filed with the SEC, including GE’s periodic report on Forms 10-K, periodic daily reports on Form 10-Q, periodic current reports on Form 8-K and other documents filed with the SEC. The anteceding list of important factors isn’t exclusive.
About GE Healthcare
GE Healthcare is the$17.7 billion healthcare business of GE (NYSE GE). As a leading global medical technology, pharmaceutical diagnostics and digital results inventor, GE Healthcare enables clinicians to make faster, more informed opinions through intelligent bias, data analytics, operations and services, supported by its Edison intelligence platform. With over 100 times of healthcare assiduity experience and around workers encyclopedically, the company operates at the center of an ecosystem working toward perfection health, digitizing healthcare, helping drive productivity and ameliorate issues for cases, providers, health systems and experimenters around the world.